Its bacteriostatic properties make it particularly advantageous for long-term storage and repeated use, minimizing the risk of contamination
It means the therapy may be worth discussing when symptoms suggest that local airway support could help, and when the patient is stable enough to tolerate inhaled treatment
However, most of the current research only focuses on the intestine, and future research is required to reveal specific relationships of intestinal diseases with other organs
Possible side effects or risks may include: Injection site pain, redness, or irritation Headache Nausea Fatigue Dizziness Fluid retention Changes in appetite Immune or allergic reactions Unwanted tissue effects Infection risk from improper injection technique Unknown long-term risks Because the long-term safety data for many emerging peptides remains limited, patients should be cautious about anyone promising guaranteed results or claiming that peptide therapy is risk-free
Pereyra AS, McLaughlin KL, Buddo KA, Ellis JM